Metabolic bone disease following organ transplantation

Se Min Kim, Sol Epstein, Tony Yuen, Li Sun, Barbara Murphy, Mone Zaid, Michael Pazianas

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Solid organ transplantation offers a valuable therapeutic option to patientswith terminal organ failure. Over the years, technical and therapeutic progress, especially the advent of new immunosuppressive agents, has signifi cantly improved outcomes. The survival rate, for example, of a kidney transplant recipient at 1-year today exceeds 95 % [1]. Graft half-life has also increased dramatically almost to 10 years [2]. As transplant recipients live longer, patients and health care providers alike have become increasingly aware of complications related to transplantation.

Original languageEnglish
Title of host publicationDiagnosis and Management of Hip Disease
Subtitle of host publicationBiological Bases of Clinical Care
PublisherSpringer International Publishing
Number of pages22
ISBN (Electronic)9783319199054
ISBN (Print)9783319199047
StatePublished - 1 Jan 2015


Dive into the research topics of 'Metabolic bone disease following organ transplantation'. Together they form a unique fingerprint.

Cite this